
National Research Corporation NRC
€ 16.32
0.37%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
National Research Corporation Langfristiger Schuldenstrom 2011-2026 | NRC
Langfristiger Schuldenstrom Jährlich National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 451 K | 550 K | 581 K | - | - | - | - | - | - | 2.68 M | 2.4 M | 2.33 M | 2.26 M | 12.4 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 12.4 M | 451 K | 2.96 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.46 | -10.44 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
1.32 M | $ 19.26 | 1.99 % | $ 558 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 16.02 | -1.05 % | $ 484 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
79 M | $ 140.19 | -2.13 % | $ 22.3 B | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 20.04 | -2.22 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 94.57 | -2.18 % | $ 6.38 B | ||
|
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 420.05 | 0.21 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 048.98 | 0.68 % | $ 21.6 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 3.62 | - | $ 335 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.3 | -0.72 % | $ 1.06 B | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 158.51 | -0.5 % | $ 7.86 B | ||
|
Natera
NTRA
|
7.64 M | $ 185.77 | -5.66 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 25.23 | -1.1 % | $ 23.9 B | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 5.84 | 0.34 % | $ 244 M | ||
|
Guardant Health
GH
|
27.7 M | $ 95.26 | -3.45 % | $ 11.9 B | ||
|
Personalis
PSNL
|
6.89 M | $ 6.46 | -3.73 % | $ 576 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 118.21 | 0.96 % | $ 9.75 B | ||
|
Soleno Therapeutics
SLNO
|
726 K | $ 52.99 | -0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 49.69 | -6.16 % | $ 2.97 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.31 | -4.04 % | $ 5.31 M | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 251.84 | -0.89 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 441.44 | -1.5 % | $ 166 B | ||
|
Celcuity
CELC
|
54 K | $ 132.6 | -1.57 % | $ 6.2 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
31.1 M | $ 332.1 | -0.33 % | $ 19.8 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 8.36 | -0.83 % | $ 1.81 B |